April is Sjögren’s Awareness Month. This is a good time to take a closer look at how this condition relates to pulmonary fibrosis (PF).
Living with PF often means learning about a wide range of underlying causes and related conditions. One of those conditions is Sjögren’s disease, an autoimmune disorder that can affect more than just the eyes and mouth.
In some individuals, Sjögren’s disease can lead to interstitial lung disease (ILD), which in some cases may progress to pulmonary fibrosis.
Understanding this connection can help patients and caregivers feel more informed, prepared, and empowered in conversations with their medical team.

What Is Sjögren’s Disease?
Sjögren’s disease (also called Sjögren’s syndrome) is an autoimmune condition, meaning the immune system mistakenly attacks healthy tissues.
It most commonly affects moisture-producing glands, leading to:
- Dry eyes
- Dry mouth
- Fatigue
- Joint pain
Sjögren’s is considered a systemic disease, which means it can affect multiple parts of the body, including the lungs.
How Does Sjögren’s Affect the Lungs?
In some individuals, Sjögren’s disease can lead to interstitial lung disease (ILD), a group of conditions that cause inflammation and scarring in the lungs.
Over time, this inflammation can progress and lead to PF.
Common lung-related manifestations may include:
- Shortness of breath
- Persistent dry cough
- Fatigue with activity
- Reduced exercise tolerance
Not everyone with Sjögren’s will develop lung involvement, but it is important to screen for. If it does occur, it becomes an important part of the disease to monitor and manage.
Diagnosis and Monitoring
Lung involvement in Sjögren’s can be subtle early on, regular monitoring is key.
Doctors may use:
- Pulmonary function tests (PFTs) to measure lung function
- High-resolution CT (HRCT) scans to look for lung changes
- Oxygen saturation monitoring
- Symptom tracking over time
Early detection can help guide treatment decisions and support long-term management.
Treatment Considerations
Treatment for Sjögren’s-related pulmonary fibrosis often focuses on:
- Reducing inflammation, such as with immunosuppressive therapies
- Slowing fibrosis progression. In some cases, antifibrotic medications may be considered
- Managing symptoms, including oxygen therapy, pulmonary rehabilitation, and supportive care
Because Sjögren’s is an autoimmune condition, treatment plans are often highly individualized and may involve collaboration between rheumatologists and pulmonologists.
Living with Sjögren’s and Pulmonary Fibrosis
Managing both conditions can feel overwhelming at times, but many patients find ways to maintain quality of life with the right support and care.
Helpful strategies may include:
- Staying active within your limits
- Participating in pulmonary rehabilitation if available
- Managing dryness symptoms alongside lung care
- Building a care team that communicates across specialties
- Connecting with others who understand the journey
You are not alone in navigating this.
Final Thoughts
Sjögren’s disease is more than a condition of dry eyes and dry mouth. For some, it is part of a broader story that includes lung involvement and pulmonary fibrosis.
Understanding the connection can help patients and caregivers:
- Ask informed questions
- Recognize symptoms earlier
- Advocate for comprehensive care
Every journey with pulmonary fibrosis is unique, and knowledge is one way to feel more in control along the way.
Medically reviewed by Dr. Elizabeth Volkmann, MD, MS
Have you or a loved one been diagnosed with Sjögren’s-related pulmonary fibrosis? You’re not alone. We invite you to share your experience and connect with others in the PF Warriors community. Your story may help someone else feel less alone. Join PF Warriors to connect with others who understand life with pulmonary fibrosis, and share your story.
Disclaimer
This blog is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor for medical concerns.

